Published Date:2024-07-25 Original Link:https://www.onenessbio.com/en/news_detail306_2.htm No 1 Date of announcement 2024/07/25 Time of announcement 19:37:02 Subject Fespixon has been included in CSE Expert consensus on wound treatment of diabetic foot ulcer (2024). The health economics analysis supports its cost-effectiveness. To which item it meets paragraph 53 Date of events 2024/07/25 Statement Date of occurrence of the...Read More